晚期NSCLC维持治疗质疑与问题解析

被引：7

作者：

刘晓晴

机构：

[1] 军事医学科学院附属医院肺部肿瘤内科

来源：

中国肺癌杂志 | 2014年 / 17卷 / 04期

关键词：

肺肿瘤; 维持治疗;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

近年来,针对晚期非小细胞肺癌的维持治疗进行了诸多临床研究,而这些研究亦已使得部分药物通过审批应用于临床实践。但是目前维持治疗仍存在诸多不容忽视的问题和质疑,如维持治疗试验设计中存在的缺陷和疏漏;维持治疗评价金标准是什么;获益人群以及维持治疗的药效经济学等问题,本文就上述问题作进一步解析。

引用

页码：289 / 293

页数：5

共 6 条

[1]

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial [J].

Zhang, Li ;

Ma, Shenglin ;

Song, Xiangqun ;

Han, Baohui ;

Cheng, Ying ;

Huang, Cheng ;

Yang, Shujun ;

Liu, Xiaoqing ;

Liu, Yunpeng ;

Lu, Shun ;

Wang, Jie ;

Zhang, Shucai ;

Zhou, Caicun ;

Zhang, Xiangwei ;

Hayashi, Nobuya ;

Wang, Mengzhao .

LANCET ONCOLOGY, 2012, 13 (05) :466-475

[2]

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial [J].

Paz-Ares, Luis ;

de Marinis, Filippo ;

Dediu, Mircea ;

Thomas, Michael ;

Pujol, Jean-Louis ;

Bidoli, Paolo ;

Molinier, Olivier ;

Sahoo, Tarini Prasad ;

Laack, Eckart ;

Reck, Martin ;

Corral, Jesus ;

Melemed, Symantha ;

John, William ;

Chouaki, Nadia ;

Zimmermann, Annamaria H. ;

Visseren-Grul, Carla ;

Gridelli, Cesare .

LANCET ONCOLOGY, 2012, 13 (03) :247-255

[3]

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study [J].

Crino, Lucio ;

Dansin, Eric ;

Garrido, Pilar ;

Griesinger, Frank ;

Laskin, Janessa ;

Pavlakis, Nick ;

Stroiakovski, Daniel ;

Thatcher, Nick ;

Tsai, Chun-Ming ;

Wu, Yi-long ;

Zhou, Caicun .

LANCET ONCOLOGY, 2010, 11 (08) :733-740

[4]

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study [J].

Cappuzzo, Federico ;

Ciuleanu, Tudor ;

Stelmakh, Lilia ;

Cicenas, Saulius ;

Szczesna, Aleksandra ;

Juhasz, Erzsebet ;

Esteban, Emilio ;

Molinier, Olivier ;

Brugger, Wolfram ;

Melezinek, Ivan ;

Klingelschmitt, Gaelle ;

Klughammer, Barbara ;

Giaccone, Giuseppe .

LANCET ONCOLOGY, 2010, 11 (06) :521-529

[5]

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study [J].

Ciuleanu, Tudor ;

Brodowicz, Thomas ;

Zielinski, Christoph ;

Kim, Joo Hang ;

Krzakowski, Maciej ;

Laack, Eckart ;

Wu, Yi-Long ;

Bover, Isabel ;

Begbie, Stephen ;

Tzekova, Valentina ;

Cucevic, Branka ;

Pereira, Jose Rodrigues ;

Yang, Sung Hyun ;

Madhavan, Jayaprakash ;

Sugarman, Katherine P. ;

Peterson, Patrick ;

John, William J. ;

Krejcy, Kurt ;

Belani, Chandra P. .

LANCET, 2009, 374 (9699) :1432-1440

[6]

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1).[J].E.A. Eisenhauer;P. Therasse;J. Bogaerts;L.H. Schwartz;D. Sargent;R. Ford;J. Dancey;S. Arbuck;S. Gwyther;M. Mooney;L. Rubinstein;L. Shankar;L. Dodd;R. Kaplan;D. Lacombe;J. Verweij.European Journal of Cancer.2008, 2

← 1 →